Related Experiment Video
Updated: Jun 8, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Increasing prevalence of nasal and rectal colonization with methicillin-resistant Staphylococcus aureus in children
Ashok Srinivasan1, Steven E Seifried, Liang Zhu
1Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-3678, USA. ashok.srinivasan@stjude.org
Background:
Infections with methicillin-resistant Staphylococcus aureus (MRSA), in community-settings, especially with strains carrying the Panton-Valentine Leukocidin (PVL) genes, have increased markedly in recent years. Colonization with S. aureus is a risk factor for infection. However, there are few studies that examine colonization and infection with PVL-positive strains of MRSA in cancer patients.
Procedure:
The epidemiology of colonization and infection with MRSA was studied in children with cancer during two time periods: 2000/2001 and 2006/2007. PVL genes were screened and spa typing performed on the isolates.
Results:
The prevalence of colonization with MRSA increased from 0.6% in 2000/2001 to 2.9% in 2006/2007 (P = 0.0003). MRSA colonization at admission was associated with infection (P < 0.0001; RR 38.32; 95% CI: 23.36-62.84). The prevalence of infection increased from 0.99% in 2000/2001 to 3.78% in 2006-2007 (P = 0.0002). Of the 32 colonized patients, 18 (56%) had infection. None of the 14 colonized but non-infected patients had dual colonization of nares and rectum, while 8 of the 18 infected patients had colonization of both of these sites (P = 0.004). Ten patients (31%) were colonized with PVL-positive strains. Patients colonized with PVL-positive strains were more likely to be colonized both in the nares and rectum (P = 0.005), and more likely to have infection (P = 0.001). Recurrent MRSA infections were seen in 22% of patients.
Conclusion:
An increasing prevalence of colonization with MRSA was observed in children with cancer at our institution. Colonization with MRSA especially with PVL-positive strains was associated with infection.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) colonization and infection increased in children with cancer. Colonization, particularly with Panton-Valentine Leukocidin (PVL)-positive MRSA strains, significantly increases infection risk.
Area of Science:
- Infectious Diseases
- Pediatric Oncology
- Microbiology
Background:
- Community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections, especially PVL-positive strains, are rising.
- S. aureus colonization is a known risk factor for infection.
- Limited data exists on MRSA colonization and infection with PVL-positive strains in pediatric cancer patients.
Purpose of the Study:
- To investigate the epidemiology of MRSA colonization and infection in children with cancer.
- To determine the prevalence of Panton-Valentine Leukocidin (PVL) genes in MRSA isolates from these patients.
- To assess the association between MRSA colonization and subsequent infection.
Main Methods:
- A longitudinal study of MRSA colonization and infection in pediatric cancer patients.
- Two-time period comparison: 2000/2001 and 2006/2007.
- Screening for PVL genes and spa typing of MRSA isolates.
Main Results:
- MRSA colonization prevalence rose from 0.6% to 2.9% (P=0.0003).
- MRSA infection prevalence increased from 0.99% to 3.78% (P=0.0002).
- Colonization at admission strongly predicted infection (RR 38.32; P<0.0001).
- PVL-positive strains were associated with dual nares/rectal colonization (P=0.005) and infection (P=0.001).
Conclusions:
- A significant increase in MRSA colonization was observed in pediatric cancer patients.
- MRSA colonization, particularly with PVL-positive strains, is a critical risk factor for infection in this vulnerable population.
- Findings highlight the need for vigilant MRSA surveillance and infection control in pediatric oncology settings.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Microbiota of the Respiratory Tract
Mismatch Repair
Development of the Oral Microbiota